TrialBlood2020

Waning of SARS-CoV-2 RBD antibodies in longitudinal convalescent plasma samples within 4 months after symptom onset.

Josée Perreault et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.